查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462907

基因递送技术市场，按模式、按应用、按方法、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Gene Delivery Technologies Market, By Mode, By Application, By Method, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年基因递送技术市场规模为 39.18 亿美元，2024 年至 2032 年CAGR为 14.5%。

基因传递技术市场-市场动态

加大新技术投入拉动市场需求

支持各种基因转移技术的研究、开发和生产的行业资金和投资的增加进一步加速了收入的成长。目前，70% 的基因和细胞治疗计划使用病毒载体，这正在推动生物递送技术的有机收入成长。为了满足不断增长的需求，营运公司正在进行大量投资，以提高病毒载体的生产能力。几种革命性的基因修饰工具的引入促进了新基因传递系统的开发，这些工具简化了科学界在基因组层面上概述疾病复杂本质的过程。正在进行的研究旨在创造适合临床的病毒和非病毒载体，以最先进的药物治疗癌症、阿兹海默症和其他疾病等严重疾病，这也增加了市场的收入。

基因传递技术市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 14.5% 左右的CAGR成长

根据模式细分，生物细分市场预计将在预测期内主导市场

从应用细分来看，2023年基因治疗占最大市场份额

根据方法细分，Ex vivo 细分市场预计将在预测期内领先市场

按地区划分，北美是 2023 年的主要收入来源

基因传递技术市场-細項分析：

全球基因传递技术市场根据模式、应用、方法和地区进行细分。

根据模式，市场分为生物、化学和物理。由于 Yescarta 和 Kymriah 的巨大成功，生物领域预计将在预测期主导市场。自从第一个基于病毒载体的基因治疗产品获得批准以来，病毒载体引起了广泛的关注。基于这些载体的研发项目数量呈指数级增长，证实了最终用户认可病毒载体作为主要传递方式。

根据应用，市场分为基础设施基因治疗、细胞治疗、疫苗和研究。基因疗法在 2023 年占据最大的市场份额，预计在预测期内将继续保持相同的格局。该类别的收入产生是由于基因药物的可接受性不断提高以及由此导致的临床研究活动数量的增加而推动的。全球基因治疗产品核准率正在上升，这进一步推动了该领域的扩张。

根据方法的不同，业界将其分为Ex vivo、In vivo、In Vitro。体外部分预计将在预测期内引领市场，因为它具有许多优点，包括减少免疫原性反应以及在将细胞重新植入患者之前评估转导效率的能力。其出色的转导效率和其他品质使其成为研究环境中的热门选择。

基因传递技术市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内引领基因传递技术市场。在美国，正在进行大量临床试验来评估基因疗法作为爱滋病毒/爱滋病、癌症和遗传性疾病潜在治疗方法的安全性和有效性。此外，参与基因传递技术生产和行销的最大企业中有相当一部分的总部设在美国。该地区在基因传递技术方面的商业主导地位可归因于几个特征。

基因递送技术市场-竞争格局：

预计公共和私人投资者对基因传递技术日益增长的兴趣将加速新公司进入市场。为了提高市场地位，领先公司还实施了一系列策略活动，包括许可、合作伙伴关係和併购。过去几年，基因递送技术业务发生了引人注目的併购。

最近的发展：

2022 年 9 月，全球基因治疗领域的领导者 Orchard Therapeutics plc 和总部位于日本的全球专业製药公司 (J-GSP) Kyowa Kirin Co., Ltd. 宣布，该公司利用最新的生物技术开发尖端医疗解决方案他们已达成最终协议，Kyowa Kirin 将收购Orchard Therapeutics。透过此次收购，Kyowa Kirin 将能够优化 Libmeldy(R) 的价值，并有效加快 Orchard Therapeutics 下一代 MPS 项目的开发，以及其他早期研究计划，包括额颞叶失智症 (FTD) 和克罗恩病的严重遗传形式。此外，Kyowa Kirin 的技能、资源和基础设施与Orchard Therapeutics 的尖端HSC 基因治疗平台技术相结合，将促进许多有前途的生物製药候选药物的持续开发，这些候选药物有可能在医疗保健领域提供变革价值，包括协和麒麟在自体免疫疾病和肿瘤学等治疗领域和适应症方面拥有丰富的经验。

目录

第一章：基因传递技术市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 基因传递技术市场片段（按模式）
    • 基因传递技术市场片段（按应用）
    • 基因传递技术市场片段（依方法）
    • 按国家/地区分類的基因传递技术市场片段
    • 按地区分類的基因传递技术市场片段
  • 竞争洞察

第 3 章：基因传递技术主要市场趋势

  • 基因传递技术市场驱动因素
    • 市场驱动因素的影响分析
  • 基因传递技术市场限制
    • 市场限制影响分析
  • 基因传递技术市场机会
  • 基因传递技术市场未来趋势

第 4 章：基因传递技术产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：基因传递技术市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：基因传递技术市场格局

  • 2023 年基因传递技术市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：基因传递技术市场 - 按模式

  • 概述
    • 按模式分類的细分市场占有率分析
    • 生物
      • 腺病毒
      • 逆转录病毒
      • 腺病毒
      • 慢病毒
      • 其他病毒
      • 非病毒性
    • 化学
    • 身体的

第 8 章：基因传递技术市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 基因治疗
    • 细胞疗法
    • 疫苗
    • 研究

第 9 章：基因传递技术市场 - 按方法

  • 概述
    • 按方法分類的细分市场占有率分析
    • 离体
    • 体内
    • 体外

第 10 章：基因传递技术市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美基因传递技术主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模及预测（按模式）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按方法）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲基因传递技术主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按模式）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按方法）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区基因传递技术主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模及预测（按模式）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依方法）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲基因传递技术主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模及预测（按模式）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按方法）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 基因传递技术中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按模式）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（依方法）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 基因传递技术产业

  • 竞争仪表板
  • 公司简介
    • QIAGEN
    • Vectalys
    • Horizon Discovery Group Co.
    • OriGene Technologies, Inc.
    • Oxford Biomedica
    • SignaGen Laboratories
    • Thermo Fisher Scientific, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • System Biosciences llc
    • Hoffmann-La Roche AG
    • Promega Corporation
    • Sirion-Biotech GmbH
    • Catalent Inc.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2365

REPORT HIGHLIGHT

Gene Delivery Technologies Market size was valued at USD 3,918 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

The method of transferring foreign genetic material-such as DNA or RNA-into host cells is known as gene delivery. For gene delivery to cause gene expression, the host cell's genome must be reached. For gene delivery to be successful, the foreign gene delivery must stay stable inside the host cell and be able to either multiply on its own or integrate into the genome. To accomplish this, foreign DNA must be created as a component of a vector that is intended to infiltrate the target host cell and transfer the transgene to that cell's genome. Recombinant viruses and synthetic vectors (viral and non-viral) are the two types of vectors that are used to transfer genes.

Gene Delivery Technologies Market- Market Dynamics

Growing investment in new technologies to propel market demand

An increase in funding and investment in the industry that supports the research, development, and production of various techniques of gene transfer accelerates the growth in revenue even more. Currently, 70% of gene and cell therapy initiatives use viral vectors, which is driving organic revenue growth for biological delivery technologies. To meet the growing demand, the operational companies are making large investments to increase the capacity at which they can produce viral vectors. The development of new gene delivery systems has been facilitated by the introduction of several revolutionary tools for genetic modifications that have simplified the process by which the scientific community has outlined the intricate nature of disease at the genomic level. Ongoing research to create clinically appropriate vectors, both viral and non-viral, to cure crippling diseases like cancer, Alzheimer's disease, and others with state-of-the-art medicines, additionally increases the market's revenue.

Gene Delivery Technologies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on mode segmentation, the biological segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Gene Therapy held the largest market share in 2023

Based on method segmentation, the Ex vivo segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Gene Delivery Technologies Market- Segmentation Analysis:

The Global Gene Delivery Technologies Market is segmented based on Mode, Application, Method, and Region.

Based on the mode, the market is categorized into Biological, Chemical and Physical. The biological segment is expected to dominate the market over the forecast period due to Yescarta's and Kymriah's enormous success. Since the first viral vector-based gene therapy products were approved, viral vectors have attracted a lot of attention. End users' approval of viral vectors as the primary delivery modality has been confirmed by the exponential rise in the number of R&D programs based on these vectors.

Based on the application, the market is divided into Infrastructure Gene Therapy, Cell Therapy, Vaccines and Research. The Gene Therapy held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. The revenue generation in this category has been driven by the increasing acceptability of gene-based medicines and the resulting rise in the number of clinical research activities. Global gene therapy product approval rates are rising, which has further fueled the segment's expansion.

Based on the method, the industry is divided into Ex vivo, In vivo and In vitro. The Ex vivo segment is expected to lead the market over the projected period because of its many benefits, including reduced immunogenic reactions and the capacity to evaluate transduction efficiency before re-implantation of cells into the patient. Its excellent transduction efficiency and other qualities make it a popular choice in research environments.

Gene Delivery Technologies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the Gene Delivery Technologies market during the forecast period. In the United States, a significant number of clinical trials are being conducted to evaluate the safety and effectiveness of gene therapy as a potential treatment for HIV/AIDS, cancer, and genetic disorders. Additionally, a sizable portion of the largest businesses involved in the production and marketing of gene delivery technology have their headquarters in the United States. The region's commercial dominance in gene delivery technology can be attributed to several characteristics.

Gene Delivery Technologies Market- Competitive Landscape:

It is projected that the growing interest in gene delivery technologies among both public and private investors would hasten the entry of new firms into the market. To improve their market position, the leading companies are also implementing a number of strategic activities, including licensing, partnerships, and mergers and acquisitions. Notable mergers and acquisitions have taken place in the gene delivery technology business in the last few years.

Recent Developments:

In September 2022, Orchard Therapeutics plc, a leader in global gene therapy, and Kyowa Kirin Co., Ltd., a Japan-based global specialty pharmaceutical company (J-GSP) that develops cutting-edge medical solutions using the newest biotechnology, announced they have entered into a definitive agreement under which Kyowa Kirin will acquire Orchard Therapeutics. Through this acquisition, Kyowa Kirin will be able to optimize the value of Libmeldy(R) and effectively expedite the development of Orchard Therapeutics' next-generation MPS programs in addition to its other early research initiatives, which include frontotemporal dementia (FTD) and a severe genetic form of Crohn's disease. Additionally, the combination of Kyowa Kirin's skills, resources, and infrastructure with Orchard Therapeutics' cutting-edge HSC gene therapy platform technology will facilitate the ongoing development of a number of promising biopharmaceutical candidates with the potential to provide transformative value in medical care, including in therapeutic areas and indications like autoimmune diseases and oncology where Kyowa Kirin has extensive experience.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN

Vectalys

Horizon Discovery Group Co.

OriGene Technologies, Inc.

Oxford Biomedica

SignaGen Laboratories

Thermo Fisher Scientific, Inc.

Takara Bio Inc.

Bio-Rad Laboratories, Inc.

System Biosciences llc

Hoffmann-La Roche AG

Promega Corporation

Sirion-Biotech GmbH

Catalent Inc.

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY MODE- MARKET ANALYSIS, 2019 - 2032

  • Biological
  • Adenovirus
  • Retrovirus
  • AAV
  • Lentivirus
  • Other viruses
  • Non-viral
  • Chemical
  • Physical

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Ex vivo
  • In vivo
  • In vitro

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Gene Delivery Technologies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Gene Delivery Technologies Market Snippet by Mode
    • 2.1.2.Gene Delivery Technologies Market Snippet by Application
    • 2.1.3.Gene Delivery Technologies Market Snippet by Method
    • 2.1.4.Gene Delivery Technologies Market Snippet by Country
    • 2.1.5.Gene Delivery Technologies Market Snippet by Region
  • 2.2.Competitive Insights

3.Gene Delivery Technologies Key Market Trends

  • 3.1.Gene Delivery Technologies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Gene Delivery Technologies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Gene Delivery Technologies Market Opportunities
  • 3.4.Gene Delivery Technologies Market Future Trends

4.Gene Delivery Technologies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Gene Delivery Technologies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Gene Delivery Technologies Market Landscape

  • 6.1.Gene Delivery Technologies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Gene Delivery Technologies Market - By Mode

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Mode, 2023 & 2032 (%)
    • 7.1.2.Biological
      • 7.1.2.1.Adenovirus
      • 7.1.2.2.Retrovirus
      • 7.1.2.3.AAV
      • 7.1.2.4.Lentivirus
      • 7.1.2.5.Other viruses
      • 7.1.2.6.Non-viral
    • 7.1.3.Chemical
    • 7.1.4.Physical

8.Gene Delivery Technologies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Gene Therapy
    • 8.1.3.Cell Therapy
    • 8.1.4.Vaccines
    • 8.1.5.Research

9.Gene Delivery Technologies Market - By Method

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Method, 2023 & 2032 (%)
    • 9.1.2.Ex vivo
    • 9.1.3.In vivo
    • 9.1.4.In vitro

10.Gene Delivery Technologies Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Gene Delivery Technologies Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Gene Delivery Technologies Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Gene Delivery Technologies Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Gene Delivery Technologies Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Gene Delivery Technologies Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Gene Delivery Technologies Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.QIAGEN
    • 11.2.2.Vectalys
    • 11.2.3.Horizon Discovery Group Co.
    • 11.2.4.OriGene Technologies, Inc.
    • 11.2.5.Oxford Biomedica
    • 11.2.6.SignaGen Laboratories
    • 11.2.7.Thermo Fisher Scientific, Inc.
    • 11.2.8.Takara Bio Inc.
    • 11.2.9.Bio-Rad Laboratories, Inc.
    • 11.2.10.System Biosciences llc
    • 11.2.11.Hoffmann-La Roche AG
    • 11.2.12.Promega Corporation
    • 11.2.13.Sirion-Biotech GmbH
    • 11.2.14.Catalent Inc.

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gene Delivery Technologies Market: Mode Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mode
  • TABLE Global Gene Delivery Technologies Market, by Mode 2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Gene Delivery Technologies Market, by Application 2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: MethodSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Method
  • TABLE Global Gene Delivery Technologies Market, by Method2019-2032 (USD Million)
  • TABLE Gene Delivery Technologies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gene Delivery Technologies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Mode, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Gene Delivery Technologies Market, by Method, 2019-2032 (USD Million)